Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drugs candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.
This is not a financial advice!
Upcoming catalysts 08/31/2024
Block buys and Insider buys recently
Rel. Vol. on 03/12/2024 at 7.45
Cup with Handle ist forming
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 3.7 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 1.8
TPs approx. 5.3
Most info on the chart.
Trade carefully!
This is not a financial advice!
Upcoming catalysts 08/31/2024
Block buys and Insider buys recently
Rel. Vol. on 03/12/2024 at 7.45
Cup with Handle ist forming
We need to stay in a bullish overal sentiment of the market. If we see a corretion, this play might doesn't work.
Keep an eye on 3.7 level, needs to get broken for a further upmove. You can take partial profits at these levels if u want to lock in gains.
SL under 1.8
TPs approx. 5.3
Most info on the chart.
Trade carefully!
LXRX
Block Trade: LXRX 1.0M @ $2.50 at the bid
LXRX
Block Trade: LXRX 500,000 @ $2.55 at the ask